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Abstract Objective: Corticoste-
roids are used in sepsis treatment to
beneﬁt outcome. However, discussion
remains on which patients will beneﬁt
from treatment. Inter-individual vari-
ations in cortisol sensitivity, mediated
through the glucocorticoid receptor,
might play a role in the observed
differences. Our aim was to study
changes in mRNA levels of three
glucocorticoid receptor splice vari-
ants in neutrophils of children with
sepsis. Patients and design:
Twenty-three children admitted to the
pediatric intensive care unit with
sepsis or septic shock were included.
Neutrophils were isolated at days 0, 3
and 7, and after recovery
([3 months). mRNA levels of the
glucocorticoid receptor splice vari-
ants GR-a (determining most of the
cortisol effect), GR-P (increasing
GR-a effect) and GR-b (inhibitor of
GR-a) were measured quantitatively.
Main results: Neutrophils from
sepsis patients showed decreased
levels of glucocorticoid receptor
mRNA of the GR-a and GR-P splice
variants on day 0 compared to after
recovery. GR-a and GR-P mRNA
levels showed a gradual recovery on
days 3 and 7 and normalized after
recovery. GR-b mRNA levels did not
change signiﬁcantly during sepsis.
GR expression was negatively corre-
lated to interleukin-6 (a measure of
disease severity, r =- 0.60,
P = 0.009). Conclusions: Children
with sepsis or septic shock showed a
transient depression of glucocorticoid
receptor mRNA in their neutrophils.
This feature may represent a tissue-
speciﬁc adaptation during sepsis
leading to increased cortisol resis-
tance of neutrophils. Our study adds
to understanding the mechanism of
cortisol sensitivity in immune cells.
Future treatment strategies, aiming at
timing and tissue speciﬁc regulation
of glucocorticoids, might beneﬁt
patients with sepsis or septic shock.
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Introduction
Sepsis is a systemic response to a severe infectious dis-
ease with a still high mortality and morbidity despite
improving treatments. Cortisol has an important role in
counter-balancing the immune activation to infection. An
adequate cortisol stress response is essential for sepsis
survival [1], but a continuing controversy exists con-
cerning the potential beneﬁt of adjunctive corticosteroids
in severe sepsis; in this regard, it is extremely important to
identify the population that might most beneﬁt from such
intervention and, in addition, identify the appropriate time
course of such intervention [2, 3]. Inter-individual varia-
tions in the endogenous cortisol response to stress might
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[4, 5].
At a tissue level, the cortisol effects are determined
by the glucocorticoid receptor [6–9]. Large interindi-
vidual variability of cortisol sensitivity has been found
in a population-based study, with hypersensitive and
resistant persons at the extremes [6]. We previously
found that genetic variants of the glucocorticoid
receptor are associated with altered cortisol sensitivity,
an altered immune response, and altered inﬂammation
[10–13]. These alterations might be mediated through
changes in glucocorticoid receptor splice variant
expression [14]. Three different 30-splice variants of the
glucocorticoid receptor have been reported: GR-a, the
most abundant, binds ligand and is functionally active;
GR-P is thought to enhance the function of GR-a [15];
and GR-b is a dominant negative inhibitor of GR-a
action [9, 16]. Changes in levels of the different splice
variants are thought to regulate glucocorticoid sensi-
tivity (i.e., the response to cortisol) in a tissue-speciﬁc
way [17, 18]. Previous animal studies show elevated
glucocorticoid receptor m-RNA levels in septic rats
correlate with protein levels of the receptor and with
the number of hormone binding sites leading to
increased glucocorticoid receptor hormone binding
activity [19]. In humans, in vitro studies of human
lymphocytes show that increased levels of GR-a and
GR-b mRNA correlate with protein levels and with
glucocorticoid sensitivity of the cells [20]. In lympho-
cytes of sepsis patients, increased cortisol sensitivity
(measured by a thymidine incorporation assay in
dexamethasone stimulated lymphocytes) has been found
compared to controls [21]. Neutrophils play an impor-
tant role in the defense against bacterial infections.
Activation of neutrophils, through infection, leads to a
pro-inﬂammatory state demonstrated by reduced apop-
tosis, increased adherence to the endothelium,
extravasation, phagocytosis and production of pro-
inﬂammatory cytokines during sepsis [22]. This leads to
a better microbial clearance, which is beneﬁcial for
combating sepsis in the acute phase [22]. However, it
also leads to tissue damage in prolonged sepsis [22],
contributing to multiple organ failure. Increasing neu-
trophil activity by down-regulating cortisol sensitivity
during sepsis could therefore enhance pathogen elimi-
nation but also augment the tissue injury. Neutrophils
and their possible changes in cortisol sensitivity during
sepsis have not been studied before at the level of the
glucocorticoid receptor.
We hypothesized that neutrophils during sepsis would
temporarily become more resistant to the anti-inﬂamma-
tory effects of cortisol by transient down-regulation of
their glucocorticoid receptor mRNA levels. Therefore,
we aimed to study changes in glucocorticoid receptor
mRNA levels in neutrophils of children with sepsis
longitudinally.
Materials and methods
Patients
Patients diagnosed with sepsis were studied within 24 h
after diagnosis. All children were admitted to the pediatric
intensive care unit. Sepsis and septic shock were deﬁned
in accordance to the criteria set forth by the International
Pediatric Sepsis Consensus Conference [23]. Shock was
deﬁned as persistent hypotension or evidence of poor
end-organ perfusion [23]. Patients with neutropenia or
immuno-suppressive therapies were excluded. The pedi-
atric risk of mortality (PRISM) score was used to
determine the severity of illness of individual patients
[24]. A higher score means a higher risk of mortality.
Blood samples were taken immediately after admission
and informed consent, on day 0 (t = 0), and at
0900 hours on day 3 (t = 3), day 7 (t = 7), and after
recovery ([3 months). Serum, stored at –20C, was used
for measurement of IL-6, using commercially available
ELISA (IL-6, Quantikine HS).
To put the results in perspective and to analyze a
possible age dependent effect, blood was obtained, for
comparison, from 20 healthy adults of the laboratory staff,
aged 21–58 years, who did not suffer from any acute or
chronic illness.
The protocol was approved by the Medical Ethics
Committee of the Erasmus University Medical Center
Rotterdam and parents gave their written informed con-
sent to the study.
Neutrophil isolation
All procedures for RNA isolation were performed imme-
diately on fresh blood in all patients. Blood (5 ml) was
drawn from an arterial catheter or venapuncture into hep-
arinized tubes. Neutrophils were isolated by the Ficoll
separation technique as described before [25]. Viability
was tested by trypan blue and more than 95% of cells were
viable. Purity of cell type subpopulation was analysed by
cytospin and ﬂow cytometric immuno-ﬂuorescence anal-
ysis and was shown to be of high purity ([98%) [25].
RNA isolation, RT-reaction, and quantitative real time
PCR
For RNA isolation, a cell suspension of 8 9 10
6 neutro-
phils in 200 ll saline was dissolved in 1 ml of trizol
reagent (Invitrogen, Breda, The Netherlands) and incu-
bated for 5 min at room temperature. After adding 0.2 ml
chloroform, tubes were shaken vigorously for 15 s and
incubated for 3 min at room temperature. After 10 min
centrifugation at 4C and 8,600g, the RNA, now in the
aqueous phase, was transferred to a new tube, precipitated
1248with 0.5 ml isopropanol, incubated for 10 min at room
temperature and centrifuged for 10 min at 4C and
8,600g. The supernatant was washed with 1 ml 70%
ethanol, vortexed and centrifuged for 5 min at 4C and
4,300g. The remaining RNA pellet was dissolved in 30 ll
RNAse-free water and incubated for 10 min at 55C.
RNA concentrations were measured using a spectropho-
tometer (Nanodrop, Los Angeles U.S.A.). The RNA
sample was stored at -80C. cDNA was synthesized from
200 ng RNA in a total volume of 50 ll, using a reverse
transcription (RT)-reaction as described previously [26].
Quantitative real time PCR was performed for GR-a,
GR-P, and GR-b splice variants. Correction for assay var-
iability was performed using the housekeeping gene
hypoxanthine phosphoribosyltransferase (HPRT) of which
expression levels are stable and not inﬂuenced by gluco-
corticoids (not shown). The primer sequences and reaction
mixusedhavebeenpreviouslydescribed[26].Thereaction
contained2 llcDNAtemplate(correspondingto8 ngtotal
RNAintheRT-PCR),2.5 llreactionbuffer,2.5 llMgCl2,
1 ll dNTP’s, 0.125 ll polymerase, 0.3 pmol/ll forward
and reverse primer (0.5 pmol/ll for HPRT), and 0.2 pmol/
ll probe, adding water to a total volume of 25 ll. The
reactions were carried out in an ABI 7700 Sequence
Detector System (Applied Biosystems, Nieuwerkerk aan
den IJssel, The Netherlands). After initial heating at 95C
for 8 min, samples were subjected to 40 cycles of dena-
turation at 92C for 15 s and annealing and synthesis for
1 min at 60C. mRNA levels of the GR-a, GR-P, GR-b
splice variants, and HPRT were calculated using the
comparative CT Method, according to the manufacturer’s
guidelines.
Statistical analysis
Data were analyzed using SPSS for windows, release
12.0.1 (SPSS, Chicago, IL, USA). For analysis of mean
splice variant expression, a paired samples t test was used.
The time course of splice variant mRNA levels at four
different time points was analyzed using mixed model
analysis, which allows the use of incomplete data in fol-
low-up. We used logarithmically transformed values of
age, CRP, IL-6, prism, cortisol, and ACTH to normalize
the distribution for these variables. Correlations between
splice variant mRNA levels and continuous variables
were analyzed using Pearson’s correlation coefﬁcient. For
analysis of differences in splice variant levels between
sexes, presence of shock, diagnosis or medication, the
independent samples t-test was used. A P value \0.05
was considered signiﬁcant.
Results
Twenty-three children with sepsis or septic shock were
included in the study (Table 1), of whom 13 (57%) were
Table 1 Patient characteristics
No Sex Age
(years)
Diagnosis Ventilated Admission
(days)
GC PRISM
score
healthy = 0
Cortisol
(nmol/l)
ref\750
ACTH
(pmol/l)
ref\40
CRP
mg/l
ref\10
IL-6
pg/ml
ref\10
1 F 1.2 Meningococcal sepsis No 1 No 7 848 365
2 F 2.3 Meningococcal sepsis No 1 No 13 1,349 3.5 84 10,494
3 M 2.7 Meningococcal sepsis No 1 No 11 638 65
4 F 2.9 Meningococcal sepsis Yes 1 Yes 17 1,645 156 334
5 F 5.8 Meningococcal sepsis Yes 2 No 11 1,006 4.8 229 135
6 M 2.4 Meningococcal sepsis No 2 Yes 19 201 2,016
7 M 2.1 Meningococcal sepsis No 2 No 5 619 2.0 89 112
8 M 3.0 Meningococcal sepsis ? shock Yes 15 No 15 696 238.0 85 30,481
9 F 4.0 Meningococcal sepsis ? shock Yes 7 No 37 782 141.0 25 362,333
10 M 0.3 Meningococcal sepsis ? shock Yes 13 No 14 995 39.3 150 13,892
11 F 1.7 Meningococcal sepsis ? shock Yes 2 No 23 601 5.2 104 15,866
12 M 5.1 Meningococcal sepsis ? shock Yes 4 No 19 1,047 13.6 51 49,526
13 M 1.4 Meningococcal sepsis ? shock Yes 5 No 31 244 179.0 78 467,433
14 M 1.8 Meningococcal sepsis ? shock Yes 1 Yes 14 394 2.4 176 688
15 M 2.1 Meningococcal sepsis ? shock Yes 2 Yes 30 2,901 1.9 408 547
16 M 2.8 Sepsis ? shock eci Yes 1 Yes 20 531 6.4 364 6,911
17 M 12.6 Sepsis eci No 0 No 3 792 1.0 91 44
18 M 7.7 Sepsis eci No 0 Yes 1 1,162 9.5 46 1,457
19 F 14.6 Toxic shock syndrome Yes 3 No 21 3,167 1.0 112 50
20 F 3.3 Toxic shock syndrome Yes 13 No 20 525 1.3 210
21 F 0.7 Pneumococcal sepsis ? shock Yes 16 Yes 29 1,241 3.2 346 22,671
22 F 2.4 Pneumococcal sepsis ? shock Yes 16 No 38 2,344 141.0 53
23 M 14.8 Staphylococcal sepsis ? shock Yes 1 No 29 1,948 4.1 323
F female, M male, GC glucocorticoid therapy: dexamethasone (no. 4, 6, 14, 16, 18, 21) or hydrocortisone (no. 15), ref healthy reference.
One patient died (no. 23), all other children recovered and are alive to date
1249male. Median age was 2.7 years (range 3 months to
14 years. The most frequent diagnosis was meningococ-
cal sepsis in 15 (65%) patients. Fourteen (61%) were
diagnosed with shock. Sixteen (70%) needed mechanical
ventilation. Median admission duration on the intensive
care unit was 2.0 days (range 1–16). Median PRISM
score was 19 (range 1–38). Glucocorticoid treatment was
used in 7 patients, etomidate in 5, midazolam in 13, and
inotropic support in 15 patients. Median leukocyte count
was 14 9 10
9/l (range 1.8–50). In the leukocyte differ-
entiation, median percentage of granulocytes was 81%
(range 26–94%), lymphocytes 14% (range 5–68%),
monocytes 3% (range 0–9%) Median level of IL-6 was
54,722 pg/ml (range 44–467,433), C-reactive protein
(CRP) at admission was 112 mg/l (range 25–408), corti-
sol 921 nmol/l (range 244–3,167), ACTH 4.8 pg/l (range
25–408) (Table 1). Of the 23 children who were included,
1 died within 24 h after diagnosis (patient 23, Table 1).
All other children recovered and are alive to date.
A blood sample was obtained from all 23 patients at
day 0, from 11 patients at day 3, from 5 patients at day 7
and from 15 patients after recovery ([3 months after
t = 0). The drop-outs on day 3 and 7 were due to prior
discharge from the ICU. No recovery sample was
obtained from 7 patients: 2 dropped out of the study
because the parents refused venapuncture after recovery,
3 were missed during follow-up, and in 2 patients RNA
isolation failed in the laboratory.
Glucocorticoid receptor mRNA levels are shown in
Fig. 1. Sepsis children showed signiﬁcantly lower levels
of GR-a and GR-P in their neutrophils at t = 0 compared
to after recovery (P = 0.00004 and 0.0001, respectively;
Fig. 1). The GR-b levels did not change signiﬁcantly (P
0.3; Fig. 1)[ 27]. Longitudinal analysis showed a linear
increase for GR-a and GR-P mRNA (P = 0.000001 and
0.0001, respectively) from t = 0 to 3 and 7 days until
recovery (Fig. 2). After recovery, mean GR-a, GR-P, and
GR-b mRNA levels were not different in sepsis patients
compared to the levels in 20 healthy adults (P
value = 0.8, 0.9, and 1.0, respectively). The ±2 SD of the
healthy adults is indicated by a dotted line in Fig. 1.
GR-a and GR-P mRNA at t = 0 were signiﬁcantly
correlated to IL-6 levels [correlation coefﬁcient -0.60
(P = 0.009) and -0.49 (P = 0.04), respectively; Table 2,
Fig. 3]. IL-6 was signiﬁcantly correlated to PRISM score
(correlation coefﬁcient 0.60, P-value 0.008). GR-a at
t = 0 was signiﬁcantly correlated to age (Table 2 and
Fig. 3). No correlation was found between age and IL-6
levels [correlation coefﬁcient -0.164 (P = 0.52)]. After
recovery, no correlation was found between age and GR
mRNA levels. No correlation was found between GR
splice variant levels at t = 0 and PRISM score, serum
levels of CRP, cortisol, or ACTH (Table 2). No differ-
ences in glucocorticoid receptor mRNA levels were found
in groups divided by gender, presence of shock, diagnosis,
or length of stay in the intensive care unit (Table 3). No
Fig. 1 Levels of glucocorticoid receptor splice variants GR-a, GR-
P, and GR-b mRNA in neutrophils of children with sepsis,
measured at day 0, 3, 7 and after recovery (X-axis). Y-axis
represents mRNA levels (copies) measured by real-time polymer-
ase chain reaction. The dotted reference lines represent the ±2S D
of healthy adults
1250differences in glucocorticoid receptor mRNA levels were
found in groups divided by medication, with the exception
of signiﬁcant lower mean GR-P levels in children who
received glucocorticoid treatment compared to children
without glucocorticoid treatment (Table 3).
Discussion
This study shows that, in neutrophils of children with
sepsis or septic shock, glucocorticoid receptor mRNA
levels are suppressed (Figs. 1 and 2). During follow-up,
the GR mRNA levels gradually increase at days 3 and 7
and have normalized after recovery (Figs. 1 and 2). Our
study demonstrates a transient decline of glucocorticoid
receptor mRNA levels in neutrophils during sepsis. This
implicates enhanced cortisol resistance and thus aug-
mented immune activation of neutrophils during sepsis.
Activated neutrophils are important in ﬁghting sepsis
[28]. After bacterial invasion of the body, they produce
an anti-infectious response by producing pro-inﬂamma-
tory mediators like cytokines and nitric oxide [28, 29].
Exogenous glucocorticoids are known to generally sup-
press the neutrophil activation status. However, in sepsis
patients with high endogenous cortisol levels, their
numbers increase and the phagocytic and bactericidal
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Table 2 Correlation of glucocorticoid receptor mRNA levels with
patient characteristics
CC P value CC P value CC P value
GR-a GR-P GR-b
Age 0.53 0.01 0.35 0.10 -0.16 0.95
PRISM -0.16 0.47 -0.14 0.52 -0.17 0.94
CRP 0.25 0.91 -0.79 0.72 -0.54 0.82
IL-6 -0.60 0.009 -0.49 0.04 -0.17 0.51
Cortisol 0.30 0.18 0.15 0.52 0.15 0.52
ACTH 0.38 0.11 -0.32 0.18 0.17 0.49
CC Correlation coefﬁcient, GR glucocorticoid receptor, PRISM
pediatric risk of mortality score, CRP C-reactive protein
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1251capacity in circulating neutrophils of septic patients have
been found to be higher than in controls [30]. This could
be a useful endogenous adaptation in the acute phase of
sepsis when ﬁghting the bacterial infection has priority.
The decrease of GR mRNA levels in sepsis neutrophils
that we found in our study could represent a tissue-speciﬁc
effect. Other studies reported glucocorticoid receptor
down-regulation as well as up-regulation in different tis-
sues, measured by protein amounts (western blots) or by
binding-assays. Reduced GR binding in liver, lung, and
spleen was seen in endotoxin-treated rats [31, 32], while
increased GR mRNA levels and binding activity were
found in muscle [19, 33]. In humans, peripheral blood
lymphocytes from sepsis patients showed an increased
cortisol sensitivity which suggests increased amount of
GR [21]. The currently available technologies provide the
possibility of measuring mRNA levels in a more precise,
quantitative way. To our knowledge, this is the ﬁrst time
that glucocorticoid receptor mRNA levels have been
studied in neutrophils during sepsis. The decrease in GR
mRNA levels in sepsis neutrophils found in our study
differs from other tissues described in literature. This
indicates a tissue-speciﬁc change in cortisol sensitivity
during sepsis. Thus, while some tissues might beneﬁt from
high cortisol levels with increased cortisol sensitivity,
other tissues may need to become cortisol-resistant to
function optimally. More studies are needed aiming at
unraveling the mechanism of tissue-speciﬁc transient
changes of glucocorticoid sensitivity. An important bar-
rier for studying tissues other than blood is the difﬁculty
of obtaining these in humans. However, in vitro cell lines
or postmortem material could be used. Development of
tissue-speciﬁc corticosteroid therapy might be important
for improving future treatment strategies.
In our study, glucocorticoid receptor mRNA levels
were negatively correlated with IL-6 (Table 2, Fig. 3).
IL-6 was also signiﬁcantly correlated to the PRISM score
(a measure of disease severity). This could imply that
severity of disease plays a role in glucocorticoid receptor
down-regulation. The gradual rise of glucocorticoid
receptor mRNAlevels ondays 3and 7alsocoincidedwith
theclinicalimprovementseenintheﬁrstweek.Previously,
IL-6 levels has been shown to be associated with outcome
with sepsis nonsurvivors showing signiﬁcantly higher
mean IL-6 levels (1,195.5 9 10
3 pg/ml) compared to
sepsis shock survivors (45.9 9 10
3 pg/ml) and sepsis
survivors(0.4 9 10
3 pg/ml)[5].Nocorrelationwasfound
betweenglucocorticoidreceptormRNAlevelsandPRISM
score, which might be explained by the broader range of
IL-6 (disentangling severity variation), compared to
PRISM. On the other hand, the negative correlation of
glucocorticoid receptor mRNA levels and IL-6 could
representadirecteffectofpro-inﬂammatorycytokineslike
IL-6 on the down-regulation of glucocorticoid receptor
mRNA expression. Previous in vitro studies showed that
after stimulation of neutrophils with pro-inﬂammatory
cytokines, a lower GR-a/GR-b ratio was found [9, 34, 35].
Another explanation could be that glucocorticoid receptor
down-regulation is a cortisol-driven phenomenon as it
coincideswithelevationofcortisollevels.Thesigniﬁcantly
decreased levels of GR-P in children with glucocorticoid
treatment may further support this hypothesis. However,
thelevelsofGR-ainglucocorticoid-treatedchildrenarenot
signiﬁcantlylower.GR-amRNAlevelsweresuppressedat
all ages, but an age-dependent correlation was found at
t = 0 in the direction of more GR down-regulation at a
younger age (Table 2, Fig. 3). Thus, the ability of sup-
pressingGRmRNAduringsepsismightdecreasewithage.
After recovery, no age-dependent variation was found in
children. Also, no difference was found between GR
mRNA levels in children after recovery and healthy adults
(Fig. 1). We have no indication that the variation of GR
mRNA levels at t = 0 was inﬂuenced by factors like gen-
der,presenceofshock,diagnosis,PRISM,plasmalevelsof
cortisol, ACTH, CRP, length of stay in the intensive care
unit,oruseofmedication,whilenoassociationswerefound
with any of these variables (Tables 2 and 3). However, our
study results might be limited by sample size.
We aimed at studying children with the advantage of
studyingpuresepsiswithoutinterferenceofchronicdisease
or medication. However, the results might not apply to
adults. In addition, the amount of blood that can be drawn
from children is limited, so protein levels could not
Table 3 Mean glucocorticoid receptor mRNA expression at t = 0
grouped by sex, diagnosis or medication
n GR-a P
value
a GR-P P
value
a GR-b P
value
a
Gender
Male 13 1.27 0.92 0.18 0.89 0.0012 0.21
Female 10 1.23 0.19 0.0048
Shock
Yes 14 1.19 0.67 0.18 0.94 0.0014 0.19
No 9 1.36 0.19 0.0055
Diagnosis: meningococcal
Yes 15 1.11 0.29 0.15 0.23 0.0036 0.44
No 8 1.54 0.24 0.0013
Length of ICU stay\7 days
Yes 16 1.34 0.52 0.18 0.83 0.0032 0.66
No
b 7 1.07 0.20 0.0018
Glucocorticoids
No 16 1.45 0.14 0.23 0.04 0.0015 0.23
Yes 7 0.82 0.08 0.0052
Ethomidate
No 18 1.43 0.09 0.21 0.27 0.0031 0.70
Yes 5 0.65 0.11 0.0017
Midazolam
No 10 1.38 0.59 0.20 0.72 0.0013 0.44
Yes 13 1.17 0.17 0.0036
Inotropic support
No 8 1.48 0.71 0.2 0.73 0.0011 0.64
Yes 15 1.14 0.18 0.0036
a Comparion of means by one-way ANOVA
b Deceased patient was analysed in the group of ICU stay[7 days
1252be measured. Measuring protein and mRNA levels simul-
taneously might be interesting to perform in adults.
Although previous studies have shown correlations [19,
20], the measurement of mRNA levels may notnecessarily
correlate with protein levels in sepsis patients. We studied
neutrophils only; studying other types of immune cells
wouldbeinteresting,butinapreviousstudywefoundthatit
is hampered by difﬁculty of isolating pure cell subpopula-
tions[25].Ficoll-separatedleukocytesofsepsispatientsare
not suitable for studying mononuclear cells because this
fraction is highly contaminated with granulocytes. Inter-
estingly, lymphocytes, which are prone to apoptosis, and
neutrophils, which are prone to proliferation during sepsis,
show opposite glucocorticoid receptor mRNA regulation.
This apparent paradox deserves further study to identify
tissue-speciﬁc regulators of GR expression and splice
variants during sepsis.
In conclusion, children with sepsis showed a transient
depression of the glucocorticoid receptor splice variants
GR-a and GR-P mRNA in their neutrophils. This feature
may represent a tissue-speciﬁc adaptation during sepsis
leading to increased cortisol resistance of neutrophils.
Understanding the mechanism of cortisol sensitivity in
immune cells could lead to development of new treatment
strategies. While some tissues beneﬁt from glucocorticoid
treatment, other tissues might not. Future treatment
strategies, aimed at timing and tissue-speciﬁc regulation
of glucocorticoids, might beneﬁt patients with sepsis or
other immune and inﬂammatory diseases.
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